Top 50 Medical Device VC Funds & Investors in Middle East (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Diffusion Capital Partners
VC Fund
|
9 | Turkey, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $439k–$2.7M |
|
Israel Innovation Authority
VC Fund
|
9 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Biotechnology, Medical Device | $100k–$6M |
|
Pontifax
VC Fund
|
8 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $4M–$104M |
|
Trendlines Group
VC Fund
|
7 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | $650k–$15M |
|
Accelmed
VC Fund
|
5 | Israel, United States | Series D, Series A | Health Care, Medical Device, Medical | $695k–$96M |
|
OurCrowd
VC Fund
|
5 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $612k–$70M |
|
Elron Ventures
VC Fund
|
4 | Israel, United States, China | Seed, Series A | Information Technology, Software, Cyber Security | $1M–$17M |
|
J-Ventures
VC Fund
|
4 | United States, Israel | Series A, Seed, Pre-Seed | Software, Health Care, Machine Learning | $2.5M–$27M |
|
Agriline
VC Fund
|
4 | Israel | Seed, Series A | Health Care, Medical Device, Medical | $1.3M–$17M |
|
Btomorrow Ventures
VC Fund
|
4 | United States, United Kingdom, India | Series A, Seed, Series B | Health Care, Wellness, Food and Beverage | |
|
Longevity Venture Partners
VC Fund
|
4 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical Device, Artificial Intelligence | $1.2M–$11M |
|
Rimonci Capital
VC Fund
|
3 | Israel, France, United States | Series A, Seed, Series B | Health Care, Medical Device, Eyewear | $3.6M–$11M |
|
OrbiMed
VC Fund
|
3 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$150M |
|
Triventures
VC Fund
|
3 | United States, Israel, Ireland | Series A, Series B | Health Care, Medical Device, Medical | $3.7M–$28M |
|
Magma Venture Partners
VC Fund
|
3 | Israel, United States, Mexico | Series A, Series B, Seed | Software, Mobile, Enterprise Software | $800k–$25M |
|
Eczacıbasi Momentum
VC Fund
|
3 | Turkey, United States | Seed, Series A | Medical Device, Information Technology, Baby | $125k–$12M |
|
OTV
VC Fund
|
3 | United States, Israel, Ghana | Series A, Series B, Seed | Health Care, Medical, Medical Device | $5M–$50M |
|
Consensus Business Group
VC Fund
|
3 | Israel, United States, United Kingdom | Seed, Series A | Health Care, Medical Device, Medical | $1M–$10M |
|
TT Ventures
VC Fund
|
3 | Turkey, United States, United Kingdom | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $1k–$2M |
|
Docor International Management
VC Fund
|
3 | Israel, United States | Series C, Series A | Health Care, Biotechnology, 3D Technology | $13M–$22M |
|
Sofinnova Partners
VC Fund
|
2 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$102M |
|
Italian Angels for Growth
VC Fund
|
2 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$11M |
|
Chartered Opus
VC Fund
|
2 | Israel | Series A | Wellness, Biotechnology, Manufacturing | $3M–$3.5M |
|
Robin Hood Ventures
VC Fund
|
2 | United States, Israel | Seed, Series A | Software, Health Care, Biotechnology | $100k–$11M |
|
Smith & Nephew
VC Fund
|
2 | Israel, United States, United Kingdom | Series B, Series C | Medical Device, Medical, Health Care | |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
2 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$100M |
|
Boston Scientific
VC Fund
|
2 | United States, Israel, Canada | Series B, Series C, Series D | Health Care, Medical Device, Biotechnology | |
|
ZORA Ventures
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Series A, Convertible Note | Health Care, Biotechnology, Internet | $1M–$7M |
|
Rapha Capital Management
VC Fund
|
2 | United States, Israel | Series A, Series C, Post-IPO Debt | Health Care, Therapeutics, Biotechnology | $3M–$35M |
|
The Chartered Group
VC Fund
|
2 | Israel | Series A, Private Equity | Biopharma, Agriculture, Health Care | |
|
Impact First Investments
VC Fund
|
2 | Israel, United States | Seed, Series A | Health Care, mHealth, Medical Device | $500k–$8M |
|
Emerge Ventures
VC Fund
|
2 | Israel, United States | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $2.5M–$31M |
|
Kli Capital
VC Fund
|
2 | United States, Israel, Mexico | Seed, Series A | Health Care, Software, Wellness | |
|
Maccabi Fund
VC Fund
|
2 | Israel, United States | Seed, Pre-Seed, Series A | Health Care, Medical Device, Artificial Intelligence | |
|
Indaco Venture Partners
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Turkey Development Fund
VC Fund
|
2 | Turkey, United Kingdom | Series A, Seed, Series B | Information Technology, Software, SaaS | |
|
Medtronic
VC Fund
|
2 | United States, Israel, China | Series C, Series B | Health Care, Medical Device, Medical | |
|
Varana Capital
VC Fund
|
2 | Israel, United States | Seed, Series A | Automotive, Autonomous Vehicles, Artificial Intelligence | |
|
ALIVE Israel HealthTech Fund
VC Fund
|
2 | Israel, United States | Series A, Series B | Health Care, Medical, Biotechnology | |
|
Eclipse
VC Fund
|
2 | United States, Canada, Israel | Series A, Series B, Seed | Software, Robotics, Artificial Intelligence | $2M–$105M |
|
XT Hi-Tech
VC Fund
|
2 | Israel, Singapore | Seed, Series A | Health Care, Agriculture, Medical Device | $3.2M–$20M |
|
Connecticut Innovations
VC Fund
|
2 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $200k–$25M |
|
Keiretsu Forum Northwest
VC Fund
|
2 | United States, Spain, Canada | Series A, Seed | Health Care, Software, Biotechnology | $507k–$8M |
|
Sanara Ventures
VC Fund
|
2 | Israel | Seed, Series A | Health Care, Medical, Medical Device | $800k–$6M |
|
Tarvenn Ventures
VC Fund
|
2 | Turkey, United States | Seed, Pre-Seed, Series A | Software, E-Commerce, SaaS | $50k–$600k |
|
Terra Venture Partners
VC Fund
|
2 | Israel, United States | Seed, Series A, Series B | Software, Machine Learning, Artificial Intelligence | $1M–$30M |
|
MTIP AG
VC Fund
|
2 | United States, United Kingdom, Spain | Series A, Series B, Series C | Health Care, Artificial Intelligence, Medical | $1.5M–$80M |
|
GlenRock Israel
VC Fund
|
2 | Israel, United States | Seed, Series B, Series A | Software, Cyber Security, Health Care | $100k–$19M |
|
Laborie Medical Technologies
VC Fund
|
2 | United States, Israel | Series A, Corporate Round | Medical, Health Care, Medical Device | $23M–$32M |
|
Clal Biotechnology Industries
VC Fund
|
2 | Israel, United States | Series A, Series B | Health Care, Biotechnology, Medical | $4M–$55M |
| Access all 50 VC funds in Middle East Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 49
- Round size: Seed $439k–$2.7M; Series A $985k–$2.5M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $32M in 2020
Portfolio highlights
- Boby.ai — Boby.ai develops artificial intelligence-supported mobile applications for end users
- V-Count — V-Count works with 550+ brands, 25.000+ locations in 105+ countries.
- PowerDev — PowerDev allows renewable energy contenders to make decisive and sustainable battery storage and green hydrogen investments.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 141
- Round size: Seed $590k–$6M; Grant $100k–$3.5M; Pre-Seed $150k–$2.5M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Q-Factor —
- Sub-Q Bionics — Sub-Q Bionics is a medtech company, that aids the management of chronic pain and debilitating symptoms of lymphedema specially for women.
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 106
- Round size: Series A $4M–$95M; Series B $20M–$100M; Series C $12M–$104M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 67
- Round size: Seed $650k–$3.2M; Series A $2.3M–$15M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
- Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 36
- Round size: Series A $695k–$24M; Series D $13M–$96M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- NeuroPace — The NeuroPace RNS System is the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides EEG data that can help improve patient care.
- UltraClear —
- GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 261
- Round size: Seed $612k–$8M; Series A $5.3M–$22M; Series B $8M–$70M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Corgi Insurance — Corgi Insurance Services, Inc. ("Corgi") is an American technology company that operates an artificial intelligence (AI)-powered insurance carrier based in San Francisco, California. Corgi Insurance develops and operates a fully integrated insurance stack using AI agents to automate traditional carrier operations, becoming the world’sfirst “AI insurance company.” The company owns multiple subsidiaries operating under a dog-themed naming convention.
- PhenOlives — PhenOlives transforms olive oil waste into nutritious, gluten-free olive flour that retains the health benefits of olive oil. The company employs a patented process to create a high-fiber ingredient suitable for various baking and cooking applications.
- BetterSeeds — The company focuses on non-GMO genome editing using CRISPR-Cas9 for creating a novel breed of seeds and crop traits that address the 21st-century agriculture challenges. BetterSeeds provides advanced seeds enabling better crops for mechanized harvesting, extreme e climate resistance, higher calory and nutrient values, and more.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Software, Cyber Security
- Stage:Seed, Series A
- Geography: Israel, United States, China
Investor stats
- Total investments: 64
- Round size: Seed $1.5M–$15M; Series A $1M–$17M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Cybersixgill — Cybersixgill is the leader in cyber threat intelligence enablement and enrichment. Their fully automated threat intelligence solutions help organizations fight cyber crime, detect phishing, data leaks, fraud and vulnerabilities as well as amplify incident response – in real-time. The Cybersixgill Investigative Portal empowers security teams withcontextual and actionable insights as well as the ability to conduct real-time investigations. Rich data feeds such as Darkfeed™ and DVE Score™ harness Cybersixgill’s unmatched intelligence collection capabilities and deliver real-time intel into organizations' existing security systems. Most recently, Cybersixgill introduced agility to threat intel with their CI/CP methodology (Continuous Investigation/Continuous Protection). Current customers include enterprises, financial services, MSSPs, governments and law enforcement entities.
- CartiHeal — Target improved outcomes in the treatment of knee cartilage and osteochondral defects with a porous, biocompatible and biodegradable off-the-shelf implant.
- Brainsgate — Established in 2000, BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases.BrainsGate's platform...
J- Ventures is a Silicon Valley based group of VC funds with over $60m under management. Backed by 400+ leading Investors ( 140+ Serial founders, 100+ VCs, 170+ Fortune 500 Executives) as LPs. Our active-LP venture fund brings the power of this connected & intellectual capital to add real value to the companies we invest in and create aremarkable difference by helping our founders grow and scale to markets quicker. Based in Silicon Valley with investors from 15 communities - Tel Aviv, NYC, LA, London, Miami, Boston, and more. Since 2016 the group made over 50 investments, 4 unicorns and over 10 exits.
Show more...Investment focus
- Industry: Software, Health Care, Machine Learning
- Stage:Series A, Seed, Pre-Seed
- Geography: United States, Israel
Investor stats
- Total investments: 67
- Round size: Seed $2.5M–$5.2M; Series A $7.7M–$27M
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely still investing — raised $32M in 2023
Portfolio highlights
- Zenskar — Zenskar seamlessly manages complex subscription and usage based billing. Meter high throughput data, and automate revenue accounting, analytics & dunning.
- CopilotKit — CopilotKit is the full-stack framework for building user interactive agents and copilots. The company behind the AG-UI Protocol.
- Nimble Way — Automate data collection with real-time pipelines. Power AI & BI with structured, cloud-integrated data for accurate insights & growth.
Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$7.5M; Series A $5M–$17M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- AgroScout — AgroScout precision agriculture solutions enable more efficient use of crop inputs including fertilizers, pesticides, tillage, and irrigation water.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more...Investment focus
- Industry: Health Care, Wellness, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 44
- Lead/follow: no public data
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Longevity Venture Partners is an early-stage venture capital firm committed to assisting entrepreneurs in the Silvertech, Healthcare, and Wellness sectors.
Show more...Investment focus
- Industry: Health Care, Medical Device, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $4M–$11M; Pre-Seed $1.2M–$3.6M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- FertilAI — FertilAI is a healthcare company developing technologies that improve the success rate of fertility treatments, elevate the patient experience, and increase clinics ability to scale. The company’s AI algorithms automate the process and assist physicians in making the best clinical decisions during treatments. The algorithms are seamlesslyintegrated into the company’s Fertilane platform. This allows effective communication between clinics, doctors, and patients using doctor/patient apps and admin webapps tailor made for the fertility workflows. FertilAI is based in Israel and was founded by a collaboration of technology experts and leading REIs including Prof. Ariel Hourvitz, Dr. Ettie Maman, and Dr. Micha Baum.
- Voxela, Inc. — Voxels is an AI powered platform on a mission to reinvent caregiving by making incident detection intelligent and actionable.
- Sensifai Health — Powered by insights from wearables, Sensifai alerts inflammatory flares before symptoms enabling true early intervention.
A dedicated to China-Israel cross border investment.
Show more...Investment focus
- Industry: Health Care, Medical Device, Eyewear
- Stage:Series A, Seed, Series B
- Geography: Israel, France, United States
Investor stats
- Total investments: 10
- Round size: Seed $3.6M–$3.6M; Series A $6.6M–$11M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
- Laclarée — Laclarée develops a pair of adaptive eyeglasses for presbyopia. Its patented technology allows the eyeglasses to adapt in real-time to the scene viewed by the wearer. This major innovation will help milllions of people 45+ years, who are not satisfied with current solutions (progressive lenses, multiple pairs, etc...).
- BELKIN Vision — Imagine an efficient, non-contact glaucoma laser treatment able to alleviate IOP painlessly. Accessible Glaucoma Care at the touch of a button.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 576
- Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$131M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- resTORbio — Restore Beauty - Rethink Bio
- Caris Life Sciences — Caris fulfills the promise of precision oncology through advanced laboratory testing, including tumor profiling and blood-based cancer diagnostics.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 60
- Round size: Series A $3.7M–$20M; Series B $6M–$28M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
- TailorMed — Moving Mountains for Patients
Magma is Israel's leading venture capital firm specializing in early-stage investments in communication, semiconductors, internet and media. They seek bright ideas, infuse them with experience and foresight, and facilitate their rise as industry leaders that redefine the global communications sector. They use their experience and sectorspecialization in cooperating with entrepreneurs, industry experts, and other investors to define the future of the communication, semiconductors, internet and media arenas. Their goal is to foster and enable the flow of innovation from an idea's early stages and through a company's emergence as a leader within its dynamic market. They understand the local market and help to influence the global one.
Show more...Investment focus
- Industry: Software, Mobile, Enterprise Software
- Stage:Series A, Series B, Seed
- Geography: Israel, United States, Mexico
Investor stats
- Total investments: 118
- Round size: Seed $800k–$6M; Series A $1.9M–$12M; Series B $6M–$25M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $24M in 2017
Portfolio highlights
- Aidoc — Aidoc is an Israel-based startup providing artificial intelligence tools for radiologists. Their products help detect and pinpoint critical anomalies for radiologists through deep learning and AI algorithms that analyze medical images and patient data. Aidoc eases up the work list and frees up time and attention to what matters. The startupdeidentifies these and sends them onto Aidoc’s cloud, where algorithms identify and highlight abnormalities before returning the images to radiology workstations for reidentification.Aidoc's s solutions aid radiologists in reducing turnaround time and increasing quality and efficiency by flagging acute anomalies in real-time. It also offers tests for intracranial hemorrhages and spinal fractures, plus several chest exams for pulmonary embolisms, pneumothorax, rib fractures, and lung nodules.Aidoc was founded by Guy Reiner, Elad Walach, and Michael Braginsky in 2016 and is headquartered in Tel Aviv, Israel.
- PayKey — The PayKey social banking and mobile P2P payment solution: A patent-pending mobile payment keyboard that seamlessly integrates with your banking application and lets users complete a transaction without leaving their social application.
- Magisto — Magisto online video editor is a fast & powerful video maker. Turn your photos and video clips into video stories with Magisto movie editor. Start free!
Eczacıbaşı Momentum invested in three venture companies and a venture capital fund; Their goal is to invest US$30 million over the next five years as they continue to partner with funds and startups that shape the new normal of modern life, focusing on well-being, consumption, and home-living.
Show more...Investment focus
- Industry: Medical Device, Information Technology, Baby
- Stage:Seed, Series A
- Geography: Turkey, United States
Investor stats
- Total investments: 8
- Round size: Seed $125k–$2.6M; Series A $2.5M–$12M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $30M in 2020
Portfolio highlights
- Newlab — Systems for scale
- Ecomercek — Ninico is a modern and flexible Minimal eCommerce Laravel script. This script is suited for electronic, organic and grocery store, furniture store, clothing store, hitech store and accessories store...
- RS Research — RS Research is a next generation therapeutics company developing novel nanomedicines. We have developed a pioneering class of nanocarriers with which we currently have proprietary programs in various stages of preclinical development for treatment of cancer.Our nanocarrier platform is highly tunable with a plug & play approach, allowingspeedy development of targeted nanomedicines with superior performance.Along with moving our very own candidates toward clinic, we provide preclinical services to industrial and academic partners. We have specific expertise in biosimilar characterization as well as in vivo experiment design.
OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Seed
- Geography: United States, Israel, Ghana
Investor stats
- Total investments: 21
- Round size: Seed $5M–$8M; Series A $6M–$12M; Series B $16M–$50M
- Lead/follow: 57% lead, 43% follow
- Last fund: May invest from a new fund soon — raised $170M in 2020
Portfolio highlights
- Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
- Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
- Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 21
- Round size: Seed $1.7M–$4.1M; Series A $1M–$10M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
- MEDX Xelerator — MEDX Xelerator is a unique medical device and digital health incubator. It was founded by MEDX Ventures Group, together with three partners: Boston Scientific, Intellectual Ventures’ Invention Science Fund and Sheba Medical Center. Each of MEDX Xelerator’s partners contributes outstanding core competencies, which complement one another and togethercreate a solid foundation for your success. Our incubator is seeking medical innovations for minimally invasive procedures, medical robotics, medical implants and digital health.Our vision is to leverage the power of MEDX Xelerator, and together with the extraordinary Israeli med tech innovation scene create a local cluster of entrepreneurial companies with breakthrough solutions to true unmet medical needs. Our mission is to nurture those promising technologies into successful medical ventures for the benefit of patients and health care professionals. We see you, the entrepreneur, as the key to success and we are here for you to make it happen.
- Synchrony Medical — Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
TT Ventures is the corporate venture capital arm of Turk Telekom.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 68
- Round size: Seed $100k–$2M; Pre-Seed $1k–$400k
- Lead/follow: 6% lead, 94% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- VenueX — VenueX enables retailers to showcase their products, POI and indoor maps to shoppers searching online!
- OctoXLabs — OctoXLabs is dedicated to tackling the most pressing challenges in the fields of Information Technology and Cybersecurity, delivering innovative solutions that enhance system resilience, data protection, and operational efficiency for organizations navigating an increasingly complex digital landscape.
- Mindsite — Mindsite provides e-commerce analytics. Easily monitor key metrics from price to visibility in real time. Increase your online sales.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, 3D Technology
- Stage:Series C, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series C $13M–$22M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 298
- Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 100
- Round size: Seed $329k–$4.6M; Angel $219k–$1.2M; Series A $2.7M–$11M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
- Fitprime — Il Partner unico per il Wellbeing Aziendale
- Alomana —
Chartered Opus offers professional market participants (clients such as asset managers) the opportunity to realise “securitised” concepts/products for their own investment or for their customers.
Show more...Investment focus
- Industry: Wellness, Biotechnology, Manufacturing
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Series A $3M–$3.5M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- SolCold — We make the sun cool again - Solcold the new environment solutions
- Trobix Bio — Trobix Bio is a company that develops and commercializes antibacterial products. It has developed platform technologies called ActiSense and GOTrap for developing high-quality products that remove the threat of antimicrobial resistance.
Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 130
- Round size: Seed $210k–$3M; Series A $100k–$11M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Epoxy.ai — We make sports viewing and gaming easy and fun for everyone
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Lia — LIA Diagnostics is redesigning pregnancy tests to addresses the challenges surrounding privacy, usability and sustainability in current pregnancy tests.
Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapysegment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series B, Series C
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
- Trice Medical — Perform a full diagnostic arthroscopy on an HD tablet thanks to the mi-eye 2. Get mi-eye 2 for your doctor's office today.
- Michelson Diagnostics — Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.
Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 70
- Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
- ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series B, Series C, Series D
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 53
- Lead/follow: no public data
Portfolio highlights
- Anumana — Anumana is a new AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention
- Nectero Medical — Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States.
- 4C Medical Technologies — 4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease. It preserves the native mitral valve and left ventricle, eliminating known issues associated with transcatheter mitral valve replacement technologies that rely on placement and fixation in the native mitral annulus and leftventricle.It was founded in 2015 and headquartered in Maple Grove, Minnesota.
Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Internet
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $1M–$7M; Series A $4M–$6M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
- Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
- Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Rapha Capital Management focused on identifying and growing revolutionary ideas in medicine, healthcare and technology before others can see their value. For inquiries, telephone and contact details are used.
Show more...Investment focus
- Industry: Health Care, Therapeutics, Biotechnology
- Stage:Series A, Series C, Post-IPO Debt
- Geography: United States, Israel
Investor stats
- Total investments: 9
- Round size: Series A $5.3M–$35M; Post-IPO Debt $3M–$7.3M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Pulmatrix — Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology. The Company's proprietary product pipeline is initially focused on advancing treatments for serious lung diseases, including Pulmazole, an inhaledanti-fungal for patients with ABPA, and PUR1800, a narrow spectrum kinase inhibitor in lung cancer. Pulmatrix's product candidates are based on iSPERSE™, its proprietary engineered dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by achieving optimal local drug concentrations and reducing systemic side effects to improve patient outcomes.
- FIZE Medical — FIZE Medical offers the first platform technology to remotely monitor and manage patients with an indwelling Foley catheter. Learn more about us >>
- AsclepiX Therapeutics — AsclepiX Therapeutics represents the next generation of biologics and drug development technology. They use bioinformatics and systems biology methods to design classes of short biomimetic anti-angiogenic (anti-neovascular), and anti-lymphangiogenic peptides. They also use the latest developments in biomaterials and drug delivery to designlong-lasting biodegradable nano and microparticles to deliver these biomimetic therapeutic peptides throughout the body.AsclepiX Therapeutics utilizes its platform technology for indications in ophthalmology, oncology, and for other angiogenesis and lymphangiogenesis-dependent diseases.
The Chartered Group is an investment platform.
Show more...Investment focus
- Industry: Biopharma, Agriculture, Health Care
- Stage:Series A, Private Equity
- Geography: Israel
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Zsquare — Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use.
- Pepticom Ltd. — Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Impact First Investments is the first Israeli impact venture capital fund with the trifold aim to bolster Israeli technology, to build global social impact, and to obtain market-rate returns.Impact investing is dynamic. It’s a web of enterprise, venture, and ingenuity with the goal to do good and do well. At Impact First, they capitalize onboldness.Technology has the ability to both address challenges and scale solutions. They capitalize and advance this interest. They recognize this growing potential of doing good and doing well, and combined with experience in Israeli high tech, they have the ability to address global social challenges by supporting social tech startups.
Show more...Investment focus
- Industry: Health Care, mHealth, Medical Device
- Stage:Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 5
- Round size: Seed $500k–$8M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- MyndYou — The Care Orchestration Platform that unites healthcare.
- EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
- General Galactic — General Galactic revolutionize the energy supply chain by producing synthetic hydrocarbons from air and waste CO2 using renewable electricity, making clean fuel affordable and accessible. General Galactic is developing technology to enable democratization of access to critical fuels at the site of need through modular hardware.
Emerge is an early stage, Tel-Aviv based Venture Capital firm, partnering with exceptional tech-innovators and helping them do whatever it takes to win.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 42
- Round size: Seed $2.5M–$11M; Series A $5M–$21M; Series B $16M–$31M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Stigg — Use Stigg's software and APIs to get easy fine-tuned control over what can be priced and packaged separately. Rapidly tweak, test and roll-out your pricing and packaging with no-code.
- Cognata — Simulation, Testing, and Validation simulation platform for Autonomous Vehicles, ADAS, Agriculture & mining machines, Defense, and more
- Deci AI — Deci enables deep learning to live up to its true potential by using AI to build better AI. With the company’s end-to-end deep learning acceleration platform, AI developers can build, optimize, and deploy faster and more accurate models for any environment, including cloud, edge or mobile. With Deci’s platform, developers can increase deeplearning model inference performance by 3x-15x, on any hardware, while still preserving accuracy. This translates directly into new use cases on limited hardware, substantially shorter development cycles, and reduced compute costs by up to 80%. The platform is powered by Deci’s Automated Neural Architecture Construction (AutoNAC) technology, an algorithmic optimization engine that squeezes maximum utilization out of any hardware. The AutoNAC engine contains a Neural Architecture Search (NAS) component that redesigns a given trained model’s architecture to optimally improve its inference performance (throughput, latency, memory, etc.) for specific target hardware while preserving its baseline accuracy. Deci achieved a record-breaking 11.8x accelerated inference speedup on Intel CPUs at MLPerf Industry Benchmark and has been named to the CBInsights top 100 AI companies. Led by a team of world-class deep learning experts, Deci lets AI developers focus on what they do best - creating innovative AI-based solutions for our world’s most complex problems.
Kli Capital is a firm focused on investing in fearless entrepreneurs who are building foundational enterprise technologies and ubiquitous consumer brands. We partner with exceptional founders with unique insights, from inception through all phases of growth.
Show more...Investment focus
- Industry: Health Care, Software, Wellness
- Stage:Seed, Series A
- Geography: United States, Israel, Mexico
Investor stats
- Total investments: 87
- Lead/follow: no public data
Portfolio highlights
- LexCheck — Transform your contract negotiation process with AI. Review, redline and approve contracts quickly and economically with the power of automation.
- VersusGame — VersusGame offers creators and brands the opportunity to cultivate a community with an interactive content solution that rewards knowledge
- Cooper — Your parenting lifeline.
Maccabi Fund is an investment fund.
Show more...Investment focus
- Industry: Health Care, Medical Device, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- AccuLine — AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide. AccuLine is developing CORA—a smart, accurate, and easy to use exam for the early detection of coronary artery disease. The clinically validated CORA evaluates a patient's risk of having coronary artery diseasethrough advanced analysis and detection of two newly discovered biomarkers in the heart’s electrical activity. CORA’s early detection will assist in the prevention of sudden cardiac deaths, while lowering costs of cardiovascular related illness.
- Rhino Federated Computing — Rhino Health utilizes Federated Learning to improve healthcare AI solutions by providing access to a large, continually updated, distributed dataset from a diverse group of patients, powering AI models that deliver consistent results and improve the standard of care.
- Olive Diagnostics — It's About me (IAM) has developed a passive sensor mounted to the rim of the toilet that performs urinalysis every time the end-user urinates. The information is uploaded to a robust data science platform to track existing and progressing conditions. Real-time, actionable notifications will be sent to the end user for proactive medical ornutritional care. Ongoing biomarker tracking for hydration, Alcohol, Pregnancy, Ovulation, Keytones, etc. is used to develop a comprehensive personal user profile.The technology will also be used for pharma and CRO companies to track the usage of drugs. While drug compliance issues plague health care systems around the world, I AM's technology will provide a reliable and continuous solution for tracking when and how people take their medicine or clinical trial drug.Nonindustrial nations will now have home access to urine lab services.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 28
- Lead/follow: no public data
Portfolio highlights
- Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Turkey Development Fund aims to develop the enterprise ecosystem by investing in new generation startups.
Show more...Investment focus
- Industry: Information Technology, Software, SaaS
- Stage:Series A, Seed, Series B
- Geography: Turkey, United Kingdom
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Rnv.ai — RNV Analytics provides AI and ML driven solutions for inventory allocation problem of retail companies. With algorithmics recommendation, their customers decide which product should be located in which sales points both online and offline.
- Delivers.AI — Delivery droid operator
- Eatron Technologies — Intelligent Software Platform for Battery Management System & Intelligent Motion Control - Eatron Technologies
Medtronic develops healthcare technology to treat chronic diseases. Its medical technology is providing lifelong solutions for people with chronic pain. The company is committed to improving lives through its medical technologies, services, and solutions. Medtronic has four main business units: the Minimally Invasive Therapies Group, the DiabetesGroup, the Restorative Therapies Group, and the Cardiac and Vascular Group. Medtronic develops and manufactures devices and therapies to treat more than 30 chronic diseases that include heart failure, Parkinson disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders, and diabetes.Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series C, Series B
- Geography: United States, Israel, China
Investor stats
- Total investments: 82
- Lead/follow: no public data
Portfolio highlights
- FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
- CathWorks — CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize PCI therapy decisions and elevate coronary angiography from visual assessment to an objective FFRangio based decision-making tool for physicians. FFR-guided PCI decision-making is proven to provide significant clinical benefits forpatients with coronary artery disease and economic benefits for patients and payers. The company’s focus is specifically on bringing the CathWorks FFRangio System to market to provide quick, precise, and objective intraprocedural FFRangio guidance that is practical for every case.
- Avation Medical — 42 million men and women have symptoms of OAB and incontinence. Vivally can help.
Varana Capital is an investment firm.
Show more...Investment focus
- Industry: Automotive, Autonomous Vehicles, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 27
- Lead/follow: no public data
Portfolio highlights
- APIGen — From connectors to entire backends, APIGen creates robust APIs from your prompts in minutes with GenAI.These APIs are complete with built-in testing, error handling, and security validations. Once created, users can download the complete codebases for these APIs and deploy them immediately to online servers—all accompanied by comprehensivedocumentation.
- CustoMED — CustoMed transforms surgical planning and execution. It does this by converting medical imaging into 3D visualizations, planning procedures, and producing customized 3D-printed surgical solutions at scale in a matter of minutes, all while streamlining the process and providing surgical excellence.
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Wisdo Health — Wisdo is an AI-powered Social Health platform harnessing the power of data and meaningful connections to improve health.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Palo Alto based Eclipse Ventures partners with entrepreneurs boldly transforming the essential industries that define and propel economies. Learn more.
Show more...Investment focus
- Industry: Software, Robotics, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 194
- Round size: Seed $2M–$24M; Series A $7.5M–$55M; Series B $15M–$105M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely still investing — raised $510M in 2023
Portfolio highlights
- Chord — Chord is a commerce data platform purpose-built for modern brands. Chord enables brands to unify, synthesize, and orchestrate their data to drive radical decisions and revenue.
- Jitsu — An expedited urban last-mile delivery service leveraging purpose-built technology and a gig driver fleet to catalyze client brand growth.
- Nucleus RadioPharma — Founded by Eclipse Ventures and Mayo Clinic, Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new treatment tools.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Established in 1997 as the venture arm of XT Holdings, XT Hi-Tech is one of the early investors in Israeli startups. Since inception, we have invested in over 80 companies in various technology categories and at different stages, including Phytech, Checkmarx, Enzymotec, Cymbio, Sofwave, and Lumenis.
Show more...Investment focus
- Industry: Health Care, Agriculture, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore
Investor stats
- Total investments: 12
- Round size: Seed $3.2M–$6.5M; Series A $6M–$20M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- BlueThrone — BlueThrone is a Technology-Driven App Appreciation Company that Buys and Grows Great iOS Apps.
- NeuReality — NeuReality is a semiconductor start-up that designs AI-as-a-service infrastructure. It addresses the challenges posed by the growing deployment of AI in the cloud, edge, and fog systems.
- Dream Security — Dream Security provides critical infrastructure defensive cyber solutions.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 245
- Round size: Seed $200k–$5M; Series A $2.4M–$25M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- Device42 — Device42 sets the standard as the most comprehensive, agentless discovery and dependency mapping solution, spanning from legacy mainframes to cloud containers.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
- NovaTract Surgical — NovaTract Surgical is a development stage company, intends to develop medical devices to address the rapidly growing field of Single Incision Laparoscopic Surgery (SILS) and Natural Orifice Transluminal Endoscopic Surgery (NOTES). The company was incorporated in 2010 and is based in Guilford, Connecticut.
Keiretsu Forum is a community of private equity investors, business leaders and entrepreneurs with a network of over 50 global chapters and more than 2,500 investor members.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed
- Geography: United States, Spain, Canada
Investor stats
- Total investments: 111
- Round size: Seed $507k–$3M; Series A $600k–$8M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- iQure Pharma — iQure Pharma preclinical and clinical drug development
- Levered Learning — Levered Learning is a classroom-tested and teacher-designed instructional system providing 3rd-5th grade mathematical learning. The company was founded in 2017 by Mitch Slater and is headquartered in Soquel, California, United States.
- Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
Sanara Ventures is an innovation-investment platform, elevating outstanding healthcare-technology companies, from early-stage to global market maturity. At Sanara, They share a vision of an integrated continuum of care supported by accessible advanced healthcare solutions for people around the world.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 7
- Round size: Seed $800k–$2.7M; Series A $4M–$6M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- QTflow Ltd. — A Micro Air Pump Technology: The Future of Thermal Management
- CVAid Medical — CVAid Medical develops an innovative AI based stroke detection technological platform.
- TailorMed — Moving Mountains for Patients
Tarvenn is an Istanbul-based international investment and advisory firm. Tarvenn has an exceptional knowledge and experience in Turkey, Balkans, Central Asia, North Africa and CIS regions. We build the future with our portfolio, international experience, corporate customers and strategic alliances. Our business is to build yours…
Show more...Investment focus
- Industry: Software, E-Commerce, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Turkey, United States
Investor stats
- Total investments: 19
- Round size: Seed $50k–$600k
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- RADAAR — A stunning social media management platform for brands, agencies, and startups that want to engage followers, publish unique content, and measure performance.
- Pixa Software — Pixa Software is an e-commerce integration and operations management platform to easily manage order processes.
- Madcraft Studios — Enhance your Trials of Osiris performance with our Destiny 2 Trials Carry guides. Learn strategies to secure wins and climb the ranks!
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Software, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 41
- Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $31M in 2013
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 23
- Round size: Series A $1.5M–$33M; Series B $10M–$30M; Series C $27M–$80M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- LynxCare — Continuously improving patient outcomes with previously unavailable insights. Find out more here.
- TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
- Koa Health — Make mental health manageable, treatable, and approachable for every industry and every individual with clinical-first care designed by experts. From evidence-based self-care and prevention through clinical treatment and therapy, Koa Health supports workforce wellbeing across the continuum.
A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.
Show more...Investment focus
- Industry: Software, Cyber Security, Health Care
- Stage:Seed, Series B, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 32
- Round size: Seed $1M–$19M; Series A $1.5M–$9M; Series B $100k–$12M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
- Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Laborie is a global medical technology company specializing in Gastroenterology, Urology & Urogynecology, and Obstetrics, Gynecology & Neonatal.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A, Corporate Round
- Geography: United States, Israel
Investor stats
- Total investments: 8
- Round size: Series A $23M–$32M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Novocuff — Novocuff is a medical device firm that aims to improve pregnancy outcomes and reduce preterm deliveries caused by PPROM and cervical shortening.
- Bright Uro — Bright Uro is an early-stage medical technology company. It is building the next generation of diagnostic devices for Urology. Utilizing advanced hardware, software, and data science can unlock new data streams and offer actionable insight for clinicians.
- Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series A $4M–$55M; Series B $15M–$33M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Middle East Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!